Sanofi and GlaxoSmithKline snag biggest coronavirus vaccine deal yet

Sanofi and GlaxoSmithKline snag biggest coronavirus vaccine deal yet
Sanofi and GlaxoSmithKline snag biggest coronavirus vaccine deal yet The arrangement brings the Trump administration’s investment in coronavirus vaccine projects to more than $8 billion. The head of the federal effort is a former GSK executive